Forecast: Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods in France

From 2013 to 2023, healthcare expenditure on pharmaceuticals and medical non-durable goods in France showed a general decline. Starting from 14.9% of total current health expenditure in 2013, it tapered to 12.84% in 2023. The average annual decline (CAGR) over the last five years was approximately 1.29%. Notable year-on-year variations include a significant drop of 8.06% in 2021 following a modest increase in 2020, and a slight decrease of 1.15% in 2023 despite a recovery of 3.59% in 2022.

Forecasted data from 2024 to 2028 suggests a continued decline, with the expenditure projected to reach 12.23% by 2028, reflecting an average annual decrease (CAGR) of around 0.77% over the period. Potential factors influencing this trend include market dynamics, policy changes, and technological advancements.

Future trends to watch for:

• Impact of new healthcare policies on pharmaceutical expenditure.
• Technological advancements, especially digital health and biopharmaceuticals.
• Shifts in consumer behavior and aging population dynamics.
• The potential resurgence of healthcare crises similar to COVID-19, which might temporarily alter expenditure patterns.